Ładuje się......
Refractory Sjögren's syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report
RATIONALE: It is known that 5% to 34% of Sjögren's syndrome (SS) cases are complicated by neuropathy in the form of myelitis. Although SS myelopathy (SSM) is often treated with glucocorticoid (GC) and immunosuppressants such as cyclophosphamide (CY), a therapeutic strategy for SSM has not been...
Zapisane w:
| Wydane w: | Medicine (Baltimore) |
|---|---|
| Główni autorzy: | , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wolters Kluwer Health
2019
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6635267/ https://ncbi.nlm.nih.gov/pubmed/31277158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016285 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|